1 result(s) for
|PI Name||Protocol #||Title|
|Skye Mayo||STUDY00016033||A Phase II study of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of Floxuridine and Dexamethasone given concurrently with systemic mFOLFIRI as a first-line therapy in patients with unresectable liver-dominant intrahepatic cholangiocarcinoma|
You may also qualify for Phase 1 Program trials.
For more information: